// App-Quantinova.ai

1472 : Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Tamara J. Dunn

Principal Investigators

  • Michaela Liedtke

  • Sharisa Cross

  • Anjali Advani

  • Paul Elson

  • Matt Kalaycio

  • Ed Copelan

  • Ronald Sobecks

  • Mikkael A. Sekeres

  • Sean Hobson

  • Laura Johnston

  • Shawnda Tench

Medical Centers

  • Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Hematologic Malignancies and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

  • Lymphocyte count

  • White Blood Cell

Drug/Treatment

  • Vincristine

  • Cytarabine liposomal

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved